Lysophospholipids as biomarkers of ovarian cancer

Authors

Rebecca Sutphen

Document Type

Patent

Publication Date

June 2011

Patent Number

7964408

Abstract

A method of using a bioactive lysophospholipid (LL) as a biomarker for detecting the presence and recurrence of ovarian cancer. Subspecies of LL, such as lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI), lysophosphatidylcholine (LPC), and lysosphingolipid sphinsosine-1-phosphate (S1P), are used alone or in conjunction to increase the specificity and sensitivity of the assay.

Application Number

10/908,484

Recommended Citation

Sutphen, Rebecca, "Lysophospholipids as biomarkers of ovarian cancer" (2011). USF Patents. 410.
https://digitalcommons.usf.edu/usf_patents/410

Assignees

University of South Florida

Filing Date

05/13/2005

Primary/U.S. Class

436/64